Elucidating the specific pharmacological mechanism of action (MOA) of naturally happening compounds can be difficult. Despite the fact that Tarselli et al. (60) designed the primary de novo synthetic pathway to conolidine and showcased that this naturally developing compound successfully suppresses responses to both chemically induced and inflammation-derived pain, https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers